The first cerctificate in China, the fifth in the world. Successfully passed WHO Emergency Use Listing (EUL) approval for the Ustars’ Molecular POC Monkeypox Virus (MPXV ) Assay.
- EasyNAT Monkeypox Virus Assay
(CE-Marked | EUL granted: 9 May 2025 | Ref: MPXV-12001-208-00)
- PortNAT Monkeypox Virus Test
(CE-Marked | EUL granted: 13 May 2025 | Ref: MPXV-13202-208-00)
This dual achievement underscores our commitment to advancing global health security through rapid, reliable diagnostics. Both assays are designed for efficient nucleic acid testing, enabling healthcare systems to respond swiftly to MPXV outbreaks.
Why it matters:
- WHO EUL approval validates the quality, safety, and efficacy of our tests for global emergency use.
- Enhances accessibility to critical diagnostics in resource-varied settings.
- Reinforces global preparedness against zoonotic threats.
Learn more about WHO EUL: https://lnkd.in/g4BD2y8j
